One of Nahdi Medical Co.’s pharmacies

Nahdi revises 2025 EPS guidance downward

NAHDI2.62%

One of Nahdi Medical Co.’s pharmacies Nahdi Medical Co. revised down its earnings per share (EPS) growth guidance to a range of 1–2% ye

To Access this Content, Please Login Or Register

To Access this Content, Please Login or Subscribe

Most Read